Research recently published in Environmental Health Perspectives describes the public health risks associated with the lack of national standards for cannabis lab testing. Researchers from Arizona State University’s School of Mathematical and Natural Sciences partnered with labs that conduct cannabis testing to data mine compliance testing records, review publicly available medical cannabis use reports, and examine regulations in all 37 U.S. jurisdictions that have legalized medical and/or recreational cannabis.

Continue Reading Study Shows Lack of Uniformity Among States’ Cannabis Testing Laws Could Lead to Public Health Risks

On Wednesday, a U.S. Court of Appeals for the First Circuit panel applied the U.S. Constitution’s Dormant Commerce Clause (DCC) to the medical cannabis industry in a 2-1 decision, striking down local laws requiring state residency as unconstitutional and protectionist. While cannabis remains federally illegal, Maine legalized medical cannabis in 2018 and imposed limitations on who could own state-legal cannabis businesses in the state.

Continue Reading First Circuit Strikes Down Maine Residency Requirement Under Dormant Commerce Clause

Perkins Coie and the National Cannabis Laboratory Council (NCLC) are proud to announce the release of “Standardizing Cannabis Lab Testing Nationally,” a white paper authored by numerous lab scientists and operators from around the country and edited by Perkins Coie attorneys.

As the legal cannabis market continues to expand, and potential federal legalization and inevitable

Cannabis: In Focus

  • New Mexico class action calls for insurance coverage for medical cannabis
  • Bicameral attempt to legislate bipartisan cannabis omnibus package
  • Oregon ban on “artificially derived cannabinoids” in cannabis products set to take effect July 1, 2022


Continue Reading Cannabis Legal Report—Week of June 19, 2022